Humoral immune response directed against LEDGF in patients with VKH
Introduction
Vogt–Koyanagi–Harada disease (VKH) is an autoimmune systemic disorder. In VKH, inflammatory disorders occur in multiple organs containing melanocytes, including uvea (resulting in acute bilateral panuveitis), skin (resulting in vitiligo and alopecia), central nervous system (resulting in meningitis), and inner ears (resulting in hearing loss and tinnitus). These inflammatory aspects are attributed to destruction of melanocytes through immunological mechanisms. In the eyes of VKH patients, T cells infiltrate diffusely throughout the choroid, whereas B lymphocytes are scattered [1]. In the skin lesion, lymphocytic infiltration was observed and infiltrating mononuclear cells primarily consisted of T lymphocytes with a smaller number of B lymphocytes [2]. Melanin-laden macrophages were specifically found in cerebrospinal fluid of patients with early stage VKH [3]. Melanoma-specific and HLA-DR-restricted T helper 1 (Th1) lymphocyte cell lines and CD4+ T cell line recognizing the tyrosinase peptide carrying the HLA-DR4 (DRB1*0405)-binding peptide motif were established from the patients [4], [5]. On the other hand, CD8+ T cell clones recognizing a MART-1 peptide in the context of HLA-A2 were also established from the patients [6]. These findings suggest that Th1-type autoreactive T cells may be involved in a development of VKH. The strong association between HLA-DR4 (DRB1*0405)-DQ4 (DQA1*0302-DQB1*0401) haplotype and the susceptibility to VKH has been noted in the Japanese and Brazilian patients; hence, HLA-linked genetic background may be related to the development of VKH [7], [8], [9], [10].
Identification of target autoantigen is important to elucidate the etiology of autoimmune diseases, and for development of antigen-specific immuno-modulation therapy. In experimental autoimmune uveitis, S-antigen and interphotoreceptor retinoid-binding protein are pathogenic autoantigens [11], [12]. However the relationship between these autoantigens and human autoimmune uveitis is uncertain. Studies have been carried out to elucidate the target autoantigen in VKH. For example, the tyrosinase family proteins were reported as the target autoantigen in VKH because peptides derived from these proteins stimulated proliferation of the lymphocytes from patients with VKH, and immunization of rats with these peptides induced autoimmunity resembled to human VHK [13], [14]. But much remains to be investigated to elucidate the exact etiology of VKH. To identify target autoantigens in autoimmune diseases, serological analysis of recombinant cDNA expression libraries (SEREX) had been done. SEREX is an immunoscreening method that makes use of procaryotically expressed cDNA libraries prepared from target organ of the autoimmune disease and sera from patients. This strategy proved effective to identify disease-related autoantigens, including type 1 diabetes, SLE, etc. [15], [16]. We used this approach to identify the target autoantigen of VKH and identified autoantigen UACA (uveal autoantigen with coiled coil domains and ankyrin repeats) [17]. But this novel UACA protein appears to be a possible target autoantigen shared by VKH, Behçet's disease (BD) and sarcoidosis that cause different types of panuveitis. In the current study, we used same approach to identify the autoantigen specific to VKH.
Section snippets
Patients
Thirty-six patients (age 19–80 years; 15 men and 21 women) with VKH were the subjects investigated in this study. All these patients underwent complete ophthalmologic and related examinations to determine the clinical diagnosis. Thirty-two patients (age 15–64 years; 20 men and 12 women) with BD complicated with panuveitis, seven patients (age 30–62 years; six men and one woman) with sympathetic ophthalmia (SO), 16 patients (age 16–67 years; two men and 14 women) with sarcoidosis complicated
Identification of immunoreactive cDNA clones
A cDNA expression library (1.5×106 pfu in primary clones) was prepared from bovine uvea, and 1.0×105 to ∼2.0×105 phage plaques were immunoscreened with each of serum obtained from four different VKH patients. A total of 6.1×105 phage plaques were screened. Twelve positive immunoreactive clones were identified in serum from one patient, JS (age 45 years, female), whereas sera from three other VKH patients did not react at detectable levels. These clones were purified, and their partial DNA
Discussion
We used the SEREX method to search for autoantigens associated with VKH. As it was impossible to obtain sufficient amounts of RNA from human uvea in Japan and because we expected there to be immunological similarities in protein population between bovine and human uvea, we used mRNA from bovine uvea to generate a cDNA expression library.
It is well established that specific autoantibodies are present in sera of patients with autoimmune diseases in which autoreactive T cells play major roles in
Acknowledgements
The authors are grateful to Dr Yuichi Obata (The Laboratory of Immunology, Aichi Cancer Center Research Institute), Dr Yutaka Kawakami (Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University Graduate School of Medical Sciences), Dr Atsushi Irie (Division of Immunogenetics, Department of Neuroscience and Immunology, Kumamoto University Graduate School of Medical Sciences) and Dr Akira Kimura (Department of Ophthalmology Kumamoto University School of Medicine)
References (42)
- et al.
Ophthalmology
(1993) - et al.
Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt–Koyanagi–Harada's disease
Hum. Immunol.
(1994) - et al.
HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt–Koyanagi–Harada disease
Hum. Immunol.
(1998) - et al.
Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats
Exp. Eye Res.
(2000) - et al.
Identification of a novel autoantigen UACA in patients with panuveitis
Biochem. Biophys. Res. Commun.
(2001) - et al.
Lens epithelium-derived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing
Gene
(2000) - et al.
Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis
J. Neuroimmunol.
(1993) - et al.
The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology
J. Neuroimmunol.
(1994) - et al.
Antibodies to lens epithelium-derived growth factor (LEDGF) kill epithelial cells of whole lenses in organ culture
Exp. Eye Res.
(1999) - et al.
Autoantibodies
Rheumatic Dis. Clin. North Am.
(1988)
Graefes
Arch. Clin. Exp. Ophthalmol.
Arch. Ophthalmol.
Br. J. Ophthalmol.
Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt–Koyanagi–Harada disease patient
Immunogenetics
Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt–Koyanagi–Harada disease
Int. Immunol.
HLA class II genes in Vogt–Koyanagi–Harada disease
Invest. Ophthalmol. Vis. Sci.
HLA-DRB1 typing of Vogt–Koyanagi–Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410
Br. J. Ophthalmol.
Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina
J. Immunol.
A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens
J. Immunol.
Tyrosinase family proteins are antigens specific to Vogt–Koyanagi–Harada disease
J. Immunol.
Cloning and expression of IDDM-specific human autoantigens
Diabetes
Cited by (61)
Investigation of dense fine speckled pattern and anti-dense fine speckled 70 antibody by a single step assay
2022, Journal of Microbiological MethodsCitation Excerpt :Dense fine speckled (DFS) pattern is found at a high frequency during routine ANA screening. The presence of autoantibodies to a dense fine speckled 70 (DFS70) antigen (also known as the lens epithelium-derived growth factor-LEDGFp75) was first shown by Ochs in patients with interstitial cystitis in 1994, followed by several diseases such as cataracts, atopic dermatitis, Vogt-Harada syndrome, prostate cancer and autoimmune thyroiditis (Ochs et al., 1994; Singh et al., 1999; Ochs et al., 2000; Yamada et al., 2001; Daniels et al., 2005; Dellavance et al., 2005). Subsequently, in a study that was carried out in a group of healthy people, it was concluded that anti-DFS70 autoantibody was more common in the healthy population than in patients with AARD.
Are the specific and nonspecific ANA staining patterns of Behçet's Disease patients important?
2022, Reumatologia ClinicaCitation Excerpt :DFS70 can be found alongside anti-p80 coilin antibodies or SS-A positivity in rheumatoid diseases. In their study on patients with Vogt-Koyanagi-Harada (VKH) Disease and Behçet's patients with panuveitis, Yamada et al. investigated LEDGF and found the anti lgG and anti-LEDGF detection rate as 66.7% in this group, as 21.6% in healthy controls, as 34% in Behçet's patients with panuveitis, and as 25.0% in sarcoidosis patients.13 LEDGF is a protein linked to the stress reaction and for this reason, can increase in inflammatory lesions and break immune tolerance, but the fact that it can be detected in healthy controls decreases the likelihood of its direct association with the disease.
Whitcup and Nussenblatt’s Uveitis: Fundamentals and Clinical Practice
2021, Whitcup and Nussenblatt's Uveitis: Fundamentals and Clinical PracticeVogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment
2016, Progress in Retinal and Eye ResearchSpecific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence
2015, Clinica Chimica ActaCitation Excerpt :This pattern is typically characterized by fine speckles uniformly distributed in the nucleus in interphase cells and in the chromatin region of metaphase cells and therefore can be distinguished from both the classic pattern that presents a homogeneous nuclear staining with positive mitoses, and the speckled nuclear pattern with negative mitoses. As the presence of anti-DFS70 antibodies has been described in patients with many diseases (e.g., allergic, neoplastic, rheumatic, autoimmune, chronic inflammatory, and in bacterial, parasitic and viral infections) [1–10] but also in healthy subjects [11,12], currently the clinical significance of its finding is not clear. Recently, it was suggested that their detection could be considered a possible exclusion criterion for SARD [11,13], especially when these antibodies occur alone [12].
- 1
Present address: Department of Ophthalmology, Hokkaido University School of Medicine, Kita 15 jou nishi 7, Kita-ku, Sapporo 060-8638, Japan.
- 2
Present address: Department of Ophthalmology, Kobe University, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.